Background Venous thromboembolism is a potentially fatal complication of hospitalisation, affecting approximately 3% of non-surgical patients. Administration of low molecular weight heparins to the appropriate patients adequately decreases venous thromboembolism incidence, but guideline adherence is notoriously low. Objective To determine the effect of a multifaceted intervention on thromboprophylaxis guideline adherence. The secondary objective was to study the effect on guideline adherence specifically in patients with a high venous thromboembolism risk. As an exploratory objective, we determined how many venous thromboembolisms may be prevented. Setting A Dutch general teaching hospital. Method A prospective study with a pre- and post-in...
Venous thromboembolism (VTE) is a major source of morbidity and mortality for both surgical and medi...
ObjectivesTo assess the treatment of venous thromboembolism (VTE) in hospitalized patients enrolled ...
Objective: To describe applicability of The International Medical Prevention Registry on Venous Thro...
Background Venous thromboembolism is a potentially fatal complication of hospitalisation, affecting ...
BACKGROUND: Consensus Conferences and Guidelines for deep vein thrombosis prophylaxis have been publ...
Background: Consensus Conferences and Guidelines for deep vein thrombosis prophylaxis have been publ...
Introduction: Venous thromboembolism (VTE) is an underestimated health problem. The administration o...
Background Prevention of recurrent venous thromboembolism (VTE) is considered a main goal of VTE ...
Background: Anticoagulant therapy is associated with a high risk of complications. Adherence to anti...
Background. Venous thromboembolism (VTE) complicates a significant proportion of medical admissions....
Objectives Venous thromboembolism is a potentially fatal complication of superficial endovenous trea...
Background Forty to 50 % of hospitalized patients with an acute medical illness have risk factors fo...
Exact publication date to be confirmed.Introduction: Venous thromboembolism (VTE) is a major cause o...
OBJECTIVES: Evaluate adherence to the therapeutic prophylaxis protocol for venous thromboembolism (V...
Hospital-associated venous thromboembolism (HA-VTE) is a major cause of morbidity and mortality and ...
Venous thromboembolism (VTE) is a major source of morbidity and mortality for both surgical and medi...
ObjectivesTo assess the treatment of venous thromboembolism (VTE) in hospitalized patients enrolled ...
Objective: To describe applicability of The International Medical Prevention Registry on Venous Thro...
Background Venous thromboembolism is a potentially fatal complication of hospitalisation, affecting ...
BACKGROUND: Consensus Conferences and Guidelines for deep vein thrombosis prophylaxis have been publ...
Background: Consensus Conferences and Guidelines for deep vein thrombosis prophylaxis have been publ...
Introduction: Venous thromboembolism (VTE) is an underestimated health problem. The administration o...
Background Prevention of recurrent venous thromboembolism (VTE) is considered a main goal of VTE ...
Background: Anticoagulant therapy is associated with a high risk of complications. Adherence to anti...
Background. Venous thromboembolism (VTE) complicates a significant proportion of medical admissions....
Objectives Venous thromboembolism is a potentially fatal complication of superficial endovenous trea...
Background Forty to 50 % of hospitalized patients with an acute medical illness have risk factors fo...
Exact publication date to be confirmed.Introduction: Venous thromboembolism (VTE) is a major cause o...
OBJECTIVES: Evaluate adherence to the therapeutic prophylaxis protocol for venous thromboembolism (V...
Hospital-associated venous thromboembolism (HA-VTE) is a major cause of morbidity and mortality and ...
Venous thromboembolism (VTE) is a major source of morbidity and mortality for both surgical and medi...
ObjectivesTo assess the treatment of venous thromboembolism (VTE) in hospitalized patients enrolled ...
Objective: To describe applicability of The International Medical Prevention Registry on Venous Thro...